Viatris Q2 2022: Revenue $4.12B, adj. EBITDA $1.48B, reaffirms guidance

Viatris Inc

2022-Q2 EPS reported $0.59 revenue$8,308,500,000

Total revenues $4.12B; U.S. GAAP net earnings $314M; adjusted EBITDA $1.48B.
Free cash flow $719M in Q2; H1 free cash flow ~$1.8B.
Reaffirms adjusted EBITDA and free cash flow guidance; revises total revenue guidance for FX.
Declares quarterly dividend $0.12 per share; paid down ~$1.5B debt in H1, on track for $2B full year.
Biocon Biologics transaction on track for H2 2022 close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.